VHL and hepatocellular carcinoma: Similarly, EVs released by adipocytes are known to transfer miR-23a/b to hepatocellular carcinoma (HCC) cells, leading to resistance against 5-fluorouracil (5-FU) by targeting the VHL/HIF axis 274.